DC

Dhiren Chandulal Shah

Active Director Director DIN 00255333
DIN 00255333 First appointment Jan 2001 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jan 2001
Shareholding value •••• Premium profile

About Dhiren Chandulal Shah

Data last updated:

Dhiren Chandulal Shah is a Director at Eastern Chemicals (Mumbai) Private Limited (since 2006), Director at Sign Pharma Trade Services Private Limited (since 2007) and Director at Trois Biotech Private Limited (since 2020). The companies operate in Chemicals and Materials, Pharma and Business Outsourcing. The 3 current companies with reported revenue have a combined latest revenue of ₹125 Cr; the largest is Eastern Chemicals (Mumbai) Private Limited at ₹115 Cr (FY 2025). Earlier, Dhiren Chandulal Shah was a Director at Saurabh Desai Exports Private Limited (2001–2024) and Director at Alvaetra Laboratories Pvt Ltd (2001–2024).

DIN 00255333
Primary Designation Director
Industry Chemicals and Materials
First Appointment 01 Jan 2001
Oldest Company Age 20 yrs
Largest company Eastern Chemicals (Mumbai) Private Limited · ₹115 Cr (FY 2025)
Combined revenue ₹125 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Apr 20062006₹115 Cr (FY 2025)Active
Director25 Sep 20072007₹9.46 Cr (FY 2025)Active
Trois Biotech Private Limited U24100MH2020PTC338789
Director13 Mar 20202020₹3,305 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jan 20011997₹12.56 Cr (FY 2024)Active
Alvaetra Laboratories Pvt Ltd U24230MH1986PTC040989
Director01 Jan 20011986₹14,722 (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Trois Biotech Private Limited
Eastern Chemicals (Mumbai) Private Limited
Sign Pharma Trade Services Private Limited
Saurabh Desai Exports Private Limited
Premium access

Shareholding and investment profile for Dhiren Chandulal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhiren Chandulal Shah

Dhiren Chandulal Shah currently holds 3 directorships: Eastern Chemicals (Mumbai) Private Limited (Director, since 26 Apr 2006, revenue ₹115 Cr (FY 2025)); Sign Pharma Trade Services Private Limited (Director, since 25 Sep 2007, revenue ₹9.46 Cr (FY 2025)); Trois Biotech Private Limited (Director, since 13 Mar 2020, revenue ₹3,305 (FY 2024)).

Dhiren Chandulal Shah was first appointed on 01 Jan 2001 as Director at Saurabh Desai Exports Private Limited. The most recent appointment on record is 13 Mar 2020 at Trois Biotech Private Limited.

The 3 current companies of Dhiren Chandulal Shah that report revenue have a combined latest revenue of ₹125 Cr: Eastern Chemicals (Mumbai) Private Limited ₹115 Cr (FY 2025); Sign Pharma Trade Services Private Limited ₹9.46 Cr (FY 2025); Trois Biotech Private Limited ₹3,305 (FY 2024).

Dhiren Chandulal Shah held 2 earlier board appointments: Saurabh Desai Exports Private Limited (Director, 01 Jan 2001 to 30 Jun 2024); Alvaetra Laboratories Pvt Ltd (Director, 01 Jan 2001 to 30 Jun 2024).

The current boards of Dhiren Chandulal Shah's companies include Chhaya Dhiren Shah (Eastern Chemicals (Mumbai) Private Limited), Dhairya Dhiren Shah (Eastern Chemicals (Mumbai) Private Limited), Hiren Pravin Doshi (Sign Pharma Trade Services Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available